Answers are grounded in this paper and cite their sources.
While bacteriophage applications benefit from effective phage engineering, selecting the desired genotype after subtle modifications remains challenging. Here, we describe a two-phase endogenous CRISPR-Cas-based phage engineering approach that enables selection of small defined edits in
No takes yet. Share an insight, caveat, or question.
Kamata et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: